Trials / Completed
CompletedNCT05671237
The Effect of Bilateral Infraorbital+ Infratrochlear Nerve Block for Rhinoplasty Operations
The Effect of Bilateral Infraorbital+ Infratrochlear Nerve Block on Perioperative Remifentanil Consumption and Postoperative Pain Scores for Rhinoplasty Operations
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Istanbul University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The aim of our study is to examine the effect of bilateral infraorbital and infratrochlear nerve blocks for rhinoplasty operations on perioperative remifentanil need and postoperative pain scores.
Detailed description
Rhinoplasty operations are one of the most applied cosmetic surgeries in the world. Depending on the procedure type and hemodynamic lability, the quality of the surgical field, perioperative and postoperative complications as well as the success of surgery are affected.To provide improved surgical field quality, controlled hypotension and high concentrations of inhalation anesthetics, magnesium sulfate, remifentanil, clonidine, calcium channel blockers, tranexamic acid, intravenous nitroglycerin have been used. The American Society of Anesthesiology recommends using regional anesthesia methods and administering multimodal analgesia in every possible surgery. In our study we have performed bilaterral infraorbital an infratrochlear nerve blocks which are main nerves of the nose, for the patients of rhinoplasty. With blocking the infratrochlear and infraorbital nerves we will examine the need for remifentanil during surgery, postoperative pain scores.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | bilateral infraorbital+infratrochlear block | we will perform bilateral infraorbital+infratrochlear nerve block |
Timeline
- Start date
- 2022-11-11
- Primary completion
- 2023-02-15
- Completion
- 2023-03-01
- First posted
- 2023-01-04
- Last updated
- 2023-06-05
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT05671237. Inclusion in this directory is not an endorsement.